News
Linda Yaccarino is taking the top job at eMed Population Health, a telehealth startup focused on GLP-1 weight loss drugs, ...
Hims & Hers Health, Inc.'s core growth and product diversification signal long-term potential, despite short-term dips. Click ...
Investors must now underwrite opportunities with a “financing risk first” mindset, says Siddhi Capital cofounder Steven Finn.
31m
FOX61 on MSNSettlement reached in lawsuit alleging sales of 'bootleg' GLP-1s without prescriptionsTriggered Brand has agreed to pay $18,500 out of a $300,000 judgment after Attorney General William Tong sued the company in ...
The online weight loss company launches a $119 starter plan using low-dose semaglutide and behavioral coaching to improve ...
The post, at the company that focuses on care for GLP-1 users, comes after Yaccarino left Elon Musk's X in July.
Linda Yaccarino, the former CEO of the Elon Musk-owned social media platform X, has a new leadership gig in the weight loss ...
Hims’ second-quarter revenue fell 7% from a quarter ago. The decline goes beyond weakness in its GLP-1 weight-loss business.
Former X CEO Linda Yaccarino has been named CEO of eMed Population Health, a health company that says it provides a “digital health platform for GLP-1/GIP population health management.” This refers to ...
Former X CEO Linda Yaccarino has taken the helm at eMed Population Health, marking a bold shift from social media to digital healthcare leadership amid rising demand for weight-loss drugs and ...
13m
Zacks.com on MSNHIMS Stock Plunges Following Q2 Earnings Miss, Gross Margin DownHims & Hers misses second-quarter 2025 EPS and revenue estimates as gross margin narrows, despite strong online sales and ...
When it comes to weight loss, there are a number of tried and true lifestyle changes you can make to help you along the way.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results